This CE activity is designed to help primary care clinicians recognize the shared mechanisms driving T2 inflammation and optimize timely referrals and interdisciplinary management. Through expert presentations and insights from patients and clinicians, participants will explore best practices for recognition, referral, and co-management with specialists. Faculty will explore evidence-based strategies for integrating targeted therapies to improve outcomes across the T2 inflammatory disease spectrum.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Address:
- 6900 Grove Road
Pricing
100% of listed courses are free
256 of 256 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- Infectious Disease
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Practice Management & Ethics
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Rhinology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1.25 credits
- MOC · Up to 1.25 points
- Commercial Support
-
ReleasedOct 31, 2025
-
Last day to claim creditOct 31, 2026 3 weeks left
-
Answers in CME Inc. (AiCME) Advancing Care for Pediatric Asthma: Targeting Type 2 Inflammation With Biologic Therapies
-
Medscape, LLC HIV, Inflammation, and Clustered Comorbidities: Assessing Risks and Proactive Management
-
Impact Education +1 Understanding Type 2 Inflammation: Best Practices in COPD Management
